NeurOp Articles
Bristol-Myers expands partnerships with Simcere and NeurOp
15 December 2011
Bristol-Myers Squibb buys rights to depression drug compounds from NeurOp for a potential $75.5 million
31 March 2010
Showing 1-2 of 2 articles
- 1
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- New study shows UCB's Neupro reduces NSBP in RLS patient
